Actinium Pharmaceuticals
ATNM
ATNM
45 hedge funds and large institutions have $3.12M invested in Actinium Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.23% less ownership
Funds ownership: 0.52% → 0.29% (-0.23%)
46% less capital invested
Capital invested by funds: $5.8M → $3.12M (-$2.68M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
45
Holding in Top 10
1
Calls
–
Puts
$1K
Top Buyers
| 1 | +$153K | |
| 2 | +$107K | |
| 3 | +$66.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$20.7K |
| 5 |
Jane Street
New York
|
+$13K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$1.2M | |
| 3 | -$147K | |
| 4 |
OC
Oppenheimer & Co
New York
|
-$49.5K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$35K |